Analysis of Serum Tumor Marker CA19-9 in the Diagnosis and Prognosis of Pancreatic Cancer-A Business Intelligence Approach
碩士 === 國立成功大學 === 高階管理碩士在職專班(EMBA) === 105 === (1) Scope and Objectives: Pancreatic cancer is a highly malignant cancer, and it is usually symptomless in the early stage, and only becomes clinically evident until the end phase of the disease course. The aim of this research is to construct a set of...
Main Authors: | Yu-XiangXue, 薛宇翔 |
---|---|
Other Authors: | Sheng-Tun Li |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/3y5fp4 |
Similar Items
-
Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer
by: Jiayu Zhang, et al.
Published: (2020-02-01) -
Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
by: Shreya Mehta, et al.
Published: (2021-07-01) -
The value oftumor markerCA 19-9in the diagnosisof chronic pancreatitis
by: A. V. Klymenko
Published: (2013-02-01) -
CA 19-9 as a serum marker in urothelial carcinoma
by: Mahander Pall, et al.
Published: (2012-01-01) -
Measurement of APRIL serum levels as a tumor marker for diagnosis of pancreatic cancer
by: Amin Hassanzadeh Nemati, et al.
Published: (2016-12-01)